Canary Speech, Inc. announced that it will apply the power of artificial intelligence (AI) voice analysis technology to address a variety of mental health...
Vega Therapeutics, Inc., a clinical stage biotechnology company developing novel therapies for rare blood disorders, announced that the U.S. Food and Drug Administration (FDA)...
Intelligent Medical Objects (IMO), a leading provider of clinical terminology management and data quality solutions for healthcare, announced that it has acquired Melax Technologies,...
Blueprint Medicines Corporation announced that the U.S. Food and Dru Administration (FDA) has approved AYVAKIT (avapritinib) for the treatment of adults with indolent systemic mastocytosis (ISM)....
BPGbio, Inc., a leading AI-powered biopharma that focuses on oncology, neurology and rare diseases, announced that it will continue clinical validation of a novel...
